bêta
IA Trial Radar
L'essai clinique NCT07320157 (HPV-Education) pour HPV (Human Papillomavirus)-Associated, HPV Immunization Status est en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
Retour à la recherche

The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake (HPV-Education) 64 Observationnel

En recrutement
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'étude' pour voir et discuter des informations sur l'étude dans la langue sélectionnée.
L'essai clinique NCT07320157 (HPV-Education) est une étude interventionnel pour HPV (Human Papillomavirus)-Associated, HPV Immunization Status. Son statut actuel est : en recrutement. L'étude a débuté le 9 janvier 2026 et vise à recruter 64 participants. Dirigée par Ufuk University, l'étude devrait être terminée d'ici le 3 avril 2026. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 22 janvier 2026.
Résumé succinct
Type of Study: This study was planned to be an observational study.

Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\[s\] it aims to answer \[is/are\]:

H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomav...

Afficher plus
Titre officiel

"Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"

Pathologies
HPV (Human Papillomavirus)-AssociatedHPV Immunization Status
Autres identifiants de l'étude
  • HPV-Education
  • E-81182178-605-56406
Numéro NCT
NCT07320157
Date de début (réel)
2026-01-09
Dernière mise à jour publiée
2026-01-22
Date de fin (estimée)
2026-04-03
Inscription (estimée)
64
Type d'étude
Interventionnel
PHASE
N/A
Statut
En recrutement
Mots clés
HPV
WOMEN
HEALTH
VACCİNE
Objectif principal
Prévention
Méthode d'allocation
N/A
Modèle d'intervention
Groupe unique
Masquage
Aucun (ouvert)
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
ExpérimentalOnline Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after deli...Afficher plus
Online Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after deli...Afficher plus
Contral Group
No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.
Critère principal d'évaluation
Critères d'évaluationDescription de la mesurePériode
Change in HPV Knowledge Score
Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.
Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)
Critère secondaire d'évaluation
Critères d'évaluationDescription de la mesurePériode
Sustained HPV Knowledge Score (Knowledge Retention)
Final follow-up (8 weeks after the first follow-up)
Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.
Assistant à la participation
Critères d'éligibilité

Âges éligibles
Adulte
Âge minimum
18 Years
Sexes éligibles
Femme
Accepte les volontaires en bonne santé
Oui
  • Being female
  • Women aged 18-35 years
  • Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
  • Having the technical equipment necessary to participate in a video interview
  • No diagnosis of HPV positivity
  • Not having received the HPV vaccine
  • Not having undergone HPV DNA/Pap smear testing in the past 5 years
  • No diagnosis of cervical cancer
  • Voluntary willingness to participate in the study
  • No diagnosis of a psychiatric disorder

  • Being male
  • Having severe physical or cognitive impairments that prevent completing the questionnaire
  • Being under 18 years of age or over 35 years of age
  • Inability to speak or understand Turkish
  • Lack of technical equipment to participate in a video interview
  • Having a diagnosis of HPV positivity
  • Having received the HPV vaccine
  • Having undergone HPV DNA/Pap smear testing in the past 5 years
  • Having a diagnosis of cervical cancer
  • Having a diagnosed psychiatric disorder

Not agreeing to participate in the study

Ufuk University logoUfuk University
Partie responsable de l'étude
Gizem Bilmez, Investigateur principal, Principal Investigator, Ufuk University
Contact central de l'étude
Contact: GİZEM B BİLMEZ GİZEM, PHD STUDENT, 905532657387, [email protected]
Contact: Duygu Akçay, Assistant Professor (PhD), +905055947466, [email protected]
1 Centres de l'étude dans 1 pays

Ankara

UfUk UNİVERSİTY, Ankara, Ankara, 06000, Turkey (Türkiye)
UFUK U BİLMEZ, GİZEM, Advanced Practice Nurse, Contact, 905532657387, [email protected]
En recrutement